Detected ·

Kinvard Bio

——

Kinvard Bio has joined the PACE portfolio, receiving funding to help advance its development of next-generation antibiotics (Oxepanoprolinamides) for serious Gram-negative infections.

Amount
—
Stage
—
Event
Funding round
Detected
2026-11-20 00:07:10 UTC
Signal ID
096a0508-a730-44a0-9410-537d73cd95ad

As the API returns it

{
  "id": "096a0508-a730-44a0-9410-537d73cd95ad",
  "created_at": "2026-11-20T00:07:10.294395Z",
  "company_name": "Kinvard Bio",
  "company_website_url": "www.kinvardbio.com",
  "company_linkedin_url": "https://www.linkedin.com/company/105666234",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*Kinvard Bio has joined the PACE portfolio, receiving funding to help advance its development of next-generation antibiotics (Oxepanoprolinamides) for serious Gram-negative infections.*"
}

Latest rounds